10/22/10 Update
Despite a terrible Tuesday, the broad market managed to eke out a small gain for the week. But dragged down by the AMLN blow-up, the biotech indexes finished in the red.
At Friday’s close, the Nasdaq Composite Index was up 9.27% YTD (vs. up 8.80% YTD a week ago), while the Nasdaq Biotech Index was up 8.81% YTD (vs. up 9.53% YTD a week ago). The Contest median closed up 9.62% YTD (vs. up 10.70% YTD a week ago).
ROCKY’s portfolio (up 49.03% YTD) picked up another percentage point and held on to the Contest lead and second place WILDER’s portfolio (up 41.56% YTD) also turned in a small weekly gain. FILO's portfolio (up 36.14% YTD) closed about even for the week and remained in third place.
At Friday's close, 26 of the 32 Contest portfolios were in the black with 18 of the 32 beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Have a safe & fun weekend biotechies!
10/22/10
Rank Name Profit/Loss
1 ROCKY 49,029
2 WILDER 41,564
3 FILO 36,144
4 MOPGCW 34,697
5 DEWDIL 32,092
6 FRED 25,954
7 GHMM 25,139
8 RKRW 22,769
9 ASHLEY 19,095
10 NIGEL 16,066
Week's Top 5 Gainers
Symbol 10/15 10/22 % change
RVX.TO 4.53 5.58 23.18%
ARYX 0.38 0.46 19.80%
MYG.TO 0.16 0.19 15.63%
AMF.TO 0.33 0.37 12.31%
NGNM.OB 1.00 1.10 10.00%
Week's Top 5 Losers
Symbol 10/15 10/22 % change
AMLN 21.04 11.30 -46.29%
ORXE.PK 0.30 0.24 -21.00%
CRME 6.50 5.72 -12.00%
ROSG 1.60 1.41 -11.88%
GTXI 3.82 3.37 -11.78% |
